MA

Mohammed Asim Hussain

Active Director Director DIN 11303545
DIN 11303545 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammed Asim Hussain

Data last updated:

Mohammed Asim Hussain is a Director at Elyso Meds Private Limited (since 2025).

DIN 11303545
Primary Designation Director
First Appointment 17 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elyso Meds Private Limited U46497KA2025PTC208618
Director17 Sep 20252025Active

Board colleagues of Mohammed Asim Hussain

NameDINCompanyDesignation
Arfathullakhan08181931Elyso Meds Private LimitedDirector
Deepak Vijay11065189Elyso Meds Private LimitedDirector
Mohamed Ali11303546Elyso Meds Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Elyso Meds Private Limited
Premium access

Shareholding and investment profile for Mohammed Asim Hussain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Asim Hussain

Mohammed Asim Hussain currently holds 1 directorship: Elyso Meds Private Limited (Director, since 17 Sep 2025).

Mohammed Asim Hussain was first appointed on 17 Sep 2025 as Director at Elyso Meds Private Limited.

The current boards of Mohammed Asim Hussain's companies include Arfathullakhan (Elyso Meds Private Limited), Deepak Vijay (Elyso Meds Private Limited), Mohamed Ali (Elyso Meds Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available